We are live on ! Find out more
IMA

ImageneBio Inc
IMA

42 hedge funds and large institutions have $82.8M invested in ImageneBio Inc in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 7

0.14% less ownership

Funds ownership: 6.17% → 6.03% (-0.14%)

9% less funds holding

Funds holding: 46 → 42 (-4)

22% less capital invested

Capital invested by funds: $106M → $82.8M (-$22.9M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
42
Holders Change
-4
Holders Change %
-8.7%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
5
Increased
18
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.16M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.47M
3
Verition Fund Management
Verition Fund Management
Connecticut
+$1.34M
4
BlackRock
BlackRock
New York
+$1.03M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$647K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.01M
2
FCM
Farallon Capital Management
California
-$1.28M
3
Millennium Management
Millennium Management
New York
-$1.04M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$181K
5
Morgan Stanley
Morgan Stanley
New York
-$114K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$17.8M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$8.97M -$9.01M -155,793 -43%
BI
3
BVF Inc
California
$8.89M – – –
OFM
4
Omega Fund Management
Massachusetts
$7.98M – – –
Citadel Advisors
5
Citadel Advisors
Florida
$7.66M +$155K +2,673 +2%
AG
6
Artal Group
Luxembourg
$5.5M – – –
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$4.77M +$3.16M +54,567 +95%
Verition Fund Management
8
Verition Fund Management
Connecticut
$4.61M +$1.34M +23,113 +27%
CA
9
CHI Advisors
New York
$4.31M +$594K +10,281 +11%
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.48M +$1.47M +25,409 +45%
LCM
11
Laurion Capital Management
New York
$1.88M – – –
BlackRock
12
BlackRock
New York
$1.78M +$1.03M +17,867 +75%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$841K +$647K +11,190 +131%
HM
14
HealthCor Management
New York
$781K – – –
Barclays
15
Barclays
United Kingdom
$714K +$636 +11 +0.1%
OMC
16
Oasis Management Company
Cayman Islands
$497K – – –
DCM
17
DAFNA Capital Management
California
$435K +$590K +10,210 New
E
18
Ergoteles
New York
$357K -$74.2K -1,283 -13%
BCM
19
Bridgeway Capital Management
Texas
$326K +$380K +6,567 +606%
Ensign Peak Advisors
20
Ensign Peak Advisors
Utah
$321K – – –
Morgan Stanley
21
Morgan Stanley
New York
$183K -$114K -1,966 -31%
State Street
22
State Street
Massachusetts
$112K -$61.2K -1,059 -29%
CIC
23
Cornercap Investment Counsel
Georgia
$105K +$61.8K +1,069 +77%
Northern Trust
24
Northern Trust
Illinois
$97K +$56.9K +984 +77%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$90K +$72.3K +1,251 +148%
1
2

IMA Hedge Fund Activity: Q3 2022 in Review

42 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2022, worth a combined $82.8M — down 22% from $106M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of IMA and 5 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 18 added.

The largest buyer was Point72 Asset Management, adding an estimated $3.16M. The largest seller was Fidelity Investments, cutting an estimated $9.01M.

  • 42 institutional investors held ImageneBio Inc (IMA) as of Q3 2022, down from 46 in Q2 2022.
  • Funds reported $82.8M of ImageneBio Inc stock for Q3 2022, down 22% quarter-over-quarter.
  • 5 funds opened new ImageneBio Inc positions in Q3 2022 and 8 closed out, a net change of -3 holders.
  • The largest ImageneBio Inc buyer in Q3 2022 was Point72 Asset Management, an estimated $3.16M added.
  • The largest ImageneBio Inc seller in Q3 2022 was Fidelity Investments, an estimated $9.01M sold.

Based on aggregated 13F filings for Q3 2022.